False Claims Act – Policy & Medicine

Pfizer’s Subsidiary Biohaven Settles for Nearly $60M Over Speaker Programs: Complaint included Significant Open Payments Under Reporting

This Week in Policy and Medicine – January 12, 2025

Federal Court Upholds Dismissal of Medicare Advantage False Claims Act Case

California Physician and Medical Practice Reach $3.8 Million False Claims Act Settlement

This Week in Policy and Medicine January 5, 2025

Besse Medical Settles for $1.67 Million Over Anti-Kickback and False Claims Allegations

Third Quarter False Claims Act Roundup

False Claims Act Case Dismissed After Briefing on Impact of Loper Bright Ruling

This Week in Policy and Medicine – December 21, 2024

DOJ Resolves More than $1 Billion in False Claims Act Settlements in First Half of 2024